Skip to main content
scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
3.390
+0.080 (2.42%)
At close: Dec 20, 2024, 4:00 PM
3.410
+0.020 (0.59%)
After-hours: Dec 20, 2024, 4:10 PM EST

scPharmaceuticals Revenue

scPharmaceuticals had revenue of $10.03M in the quarter ending September 30, 2024, with 164.12% growth. This brings the company's revenue in the last twelve months to $30.28M, up 303.87% year-over-year. In the year 2023, scPharmaceuticals had annual revenue of $13.59M.

Revenue (ttm)
$30.28M
Revenue Growth
+303.87%
P/S Ratio
4.57
Revenue / Employee
$222,632
Employees
136
Market Cap
169.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.59M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nutex Health 292.00M
Nektar Therapeutics 93.14M
BrainsWay 38.63M
Innate Pharma 36.20M
Caribou Biosciences 11.48M
EUDA Health Holdings 3.81M
Lyell Immunopharma 63.00K
Revenue Rankings

SCPH News

More News